ClinConnect ClinConnect Logo
Search / Trial NCT06953141

Ultrasound for Assessment of Intra-Abdominal Blood Loss After Gynecological Surgery

Launched by HOLY FAMILY HOSPITAL, NAZARETH, ISRAEL · Apr 29, 2025

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying how well ultrasound can help doctors understand and manage blood loss in women after gynecological surgery. Specifically, it aims to measure a blood vessel called the inferior vena cava (IVC) using advanced ultrasound techniques within 24 hours after surgery. Researchers want to see if these measurements can help predict complications like drops in hemoglobin (a protein in blood), the need for blood transfusions, pain levels, infections, and how long patients stay in the hospital.

To be eligible for this study, women aged 18 years and older who are having major gynecological surgeries like laparotomy (a large incision in the abdomen), laparoscopy (a minimally invasive procedure), or vaginal surgery can participate. Participants will undergo ultrasound exams after their surgeries and will be monitored for their recovery. The goal is to improve patient care by using these ultrasound findings to make better decisions about treatment and potentially reduce unnecessary procedures. It's important to note that the trial is not yet recruiting participants.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Women aged 18 years and older
  • Undergoing gynecological surgery including laparotomy, laparoscopy, and vaginal pelvic surgery
  • Able to provide informed consent
  • Exclusion Criteria:
  • Undergoing minor procedures (e.g., dilation and curettage, hysteroscopy, or cervical conization)
  • Known preoperative coagulation disorders
  • Postoperative admission to the intensive care unit (ICU)
  • Clinical indication requiring ultrasound as part of standard postoperative care

About Holy Family Hospital, Nazareth, Israel

Holy Family Hospital, located in Nazareth, Israel, is a prominent healthcare institution dedicated to providing high-quality medical services and advancing clinical research. As a clinical trial sponsor, the hospital is committed to enhancing patient care through innovative research initiatives that explore new treatments and therapies. With a focus on patient safety and ethical standards, Holy Family Hospital collaborates with healthcare professionals and researchers to contribute valuable insights to the medical community, ultimately aiming to improve health outcomes for diverse populations.

Locations

Nazareth, , Israel

Patients applied

0 patients applied

Trial Officials

Raed Salim, MD

Study Chair

Holy Family Hospital, Nazareth, Israel

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported